{"id":52317,"date":"2024-01-01T00:00:00","date_gmt":"2024-01-01T00:00:00","guid":{"rendered":"https:\/\/ibima.eu\/real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog\/"},"modified":"2025-04-10T10:42:24","modified_gmt":"2025-04-10T10:42:24","slug":"real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog","status":"publish","type":"post","link":"https:\/\/ibima.eu\/es\/real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog\/","title":{"rendered":"Real-World Evidence of Off-Label Use of Commercially Automated Insulin Delivery Systems Compared to Multiple Daily Insulin Injections in Pregnancies Complicated by Type 1 Diabetes &#8211; DIABETES TECHNOLOGY &#038; THERAPEUTICS"},"content":{"rendered":"<p>Quir\u00f3s, C; Arranz, MTH; Amig\u00f3, J; W\u00e4gner, AM; Beato-Vibora, PI; Azriel-Mira, S; Climent, E; Soldevila, B; Barquiel, B; Colomo, N; Dur\u00e1n-Mart\u00ednez, M; Corcoy, R; Codina, M; D\u00edaz-Soto, G; Pardo, RM; Mart\u00ednez-Brocca, MA; Roman, AR; L\u00f3pez-Gallardo, G; Cuesta, M; Fern\u00e1ndez, JG; Goya, M; Guedes, BV; Mathison, LCM; Perea, V &#8211; 2024 &#8211; 10.1089\/dia.2023.0594<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Quir\u00f3s, C; Arranz, MTH; Amig\u00f3, J; W\u00e4gner, AM; Beato-Vibora, PI; Azriel-Mira, S; Climent, E; Soldevila, B; Barquiel, B; Colomo, N; Dur\u00e1n-Mart\u00ednez, M; Corcoy, R; Codina, M; D\u00edaz-Soto, G; Pardo, RM; Mart\u00ednez-Brocca, MA; Roman, AR; L\u00f3pez-Gallardo, G; Cuesta, M; Fern\u00e1ndez, JG; Goya, M; Guedes, BV; Mathison, LCM; Perea, V &#8211; 2024 &#8211; 10.1089\/dia.2023.0594<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1578],"tags":[],"class_list":["post-52317","post","type-post","status-publish","format-standard","hentry","category-publicaciones-a-01"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Real-World Evidence of Off-Label Use of Commercially Automated Insulin Delivery Systems Compared to Multiple Daily Insulin Injections in Pregnancies Complicated by Type 1 Diabetes - DIABETES TECHNOLOGY &amp; THERAPEUTICS - Ibima<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibima.eu\/es\/real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Real-World Evidence of Off-Label Use of Commercially Automated Insulin Delivery Systems Compared to Multiple Daily Insulin Injections in Pregnancies Complicated by Type 1 Diabetes - DIABETES TECHNOLOGY &amp; THERAPEUTICS - Ibima\" \/>\n<meta property=\"og:description\" content=\"Quir\u00f3s, C; Arranz, MTH; Amig\u00f3, J; W\u00e4gner, AM; Beato-Vibora, PI; Azriel-Mira, S; Climent, E; Soldevila, B; Barquiel, B; Colomo, N; Dur\u00e1n-Mart\u00ednez, M; Corcoy, R; Codina, M; D\u00edaz-Soto, G; Pardo, RM; Mart\u00ednez-Brocca, MA; Roman, AR; L\u00f3pez-Gallardo, G; Cuesta, M; Fern\u00e1ndez, JG; Goya, M; Guedes, BV; Mathison, LCM; Perea, V &#8211; 2024 &#8211; 10.1089\/dia.2023.0594\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibima.eu\/es\/real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog\/\" \/>\n<meta property=\"og:site_name\" content=\"Ibima\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-01T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-10T10:42:24+00:00\" \/>\n<meta name=\"author\" content=\"prodriguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"prodriguez\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog\\\/\"},\"author\":{\"name\":\"prodriguez\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\"},\"headline\":\"Real-World Evidence of Off-Label Use of Commercially Automated Insulin Delivery Systems Compared to Multiple Daily Insulin Injections in Pregnancies Complicated by Type 1 Diabetes &#8211; DIABETES TECHNOLOGY &#038; THERAPEUTICS\",\"datePublished\":\"2024-01-01T00:00:00+00:00\",\"dateModified\":\"2025-04-10T10:42:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog\\\/\"},\"wordCount\":86,\"commentCount\":0,\"articleSection\":[\"Publicaciones - A-01\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog\\\/\",\"url\":\"https:\\\/\\\/ibima.eu\\\/real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog\\\/\",\"name\":\"Real-World Evidence of Off-Label Use of Commercially Automated Insulin Delivery Systems Compared to Multiple Daily Insulin Injections in Pregnancies Complicated by Type 1 Diabetes - DIABETES TECHNOLOGY & THERAPEUTICS - Ibima\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\"},\"datePublished\":\"2024-01-01T00:00:00+00:00\",\"dateModified\":\"2025-04-10T10:42:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Real-World Evidence of Off-Label Use of Commercially Automated Insulin Delivery Systems Compared to Multiple Daily Insulin Injections in Pregnancies Complicated by Type 1 Diabetes &#8211; DIABETES TECHNOLOGY &#038; THERAPEUTICS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\",\"name\":\"Ibima\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibima.eu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\",\"name\":\"prodriguez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"caption\":\"prodriguez\"},\"sameAs\":[\"https:\\\/\\\/ibima.eu\"],\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/author\\\/prodriguez\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Real-World Evidence of Off-Label Use of Commercially Automated Insulin Delivery Systems Compared to Multiple Daily Insulin Injections in Pregnancies Complicated by Type 1 Diabetes - DIABETES TECHNOLOGY & THERAPEUTICS - Ibima","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibima.eu\/es\/real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog\/","og_locale":"es_ES","og_type":"article","og_title":"Real-World Evidence of Off-Label Use of Commercially Automated Insulin Delivery Systems Compared to Multiple Daily Insulin Injections in Pregnancies Complicated by Type 1 Diabetes - DIABETES TECHNOLOGY & THERAPEUTICS - Ibima","og_description":"Quir\u00f3s, C; Arranz, MTH; Amig\u00f3, J; W\u00e4gner, AM; Beato-Vibora, PI; Azriel-Mira, S; Climent, E; Soldevila, B; Barquiel, B; Colomo, N; Dur\u00e1n-Mart\u00ednez, M; Corcoy, R; Codina, M; D\u00edaz-Soto, G; Pardo, RM; Mart\u00ednez-Brocca, MA; Roman, AR; L\u00f3pez-Gallardo, G; Cuesta, M; Fern\u00e1ndez, JG; Goya, M; Guedes, BV; Mathison, LCM; Perea, V &#8211; 2024 &#8211; 10.1089\/dia.2023.0594","og_url":"https:\/\/ibima.eu\/es\/real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog\/","og_site_name":"Ibima","article_published_time":"2024-01-01T00:00:00+00:00","article_modified_time":"2025-04-10T10:42:24+00:00","author":"prodriguez","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"prodriguez"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ibima.eu\/real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog\/#article","isPartOf":{"@id":"https:\/\/ibima.eu\/real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog\/"},"author":{"name":"prodriguez","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"headline":"Real-World Evidence of Off-Label Use of Commercially Automated Insulin Delivery Systems Compared to Multiple Daily Insulin Injections in Pregnancies Complicated by Type 1 Diabetes &#8211; DIABETES TECHNOLOGY &#038; THERAPEUTICS","datePublished":"2024-01-01T00:00:00+00:00","dateModified":"2025-04-10T10:42:24+00:00","mainEntityOfPage":{"@id":"https:\/\/ibima.eu\/real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog\/"},"wordCount":86,"commentCount":0,"articleSection":["Publicaciones - A-01"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ibima.eu\/real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ibima.eu\/real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog\/","url":"https:\/\/ibima.eu\/real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog\/","name":"Real-World Evidence of Off-Label Use of Commercially Automated Insulin Delivery Systems Compared to Multiple Daily Insulin Injections in Pregnancies Complicated by Type 1 Diabetes - DIABETES TECHNOLOGY & THERAPEUTICS - Ibima","isPartOf":{"@id":"https:\/\/ibima.eu\/es\/#website"},"datePublished":"2024-01-01T00:00:00+00:00","dateModified":"2025-04-10T10:42:24+00:00","author":{"@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"breadcrumb":{"@id":"https:\/\/ibima.eu\/real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibima.eu\/real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ibima.eu\/real-world-evidence-of-off-label-use-of-commercially-automated-insulin-delivery-systems-compared-to-multiple-daily-insulin-injections-in-pregnancies-complicated-by-type-1-diabetes-diabetes-technolog\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibima.eu\/es\/"},{"@type":"ListItem","position":2,"name":"Real-World Evidence of Off-Label Use of Commercially Automated Insulin Delivery Systems Compared to Multiple Daily Insulin Injections in Pregnancies Complicated by Type 1 Diabetes &#8211; DIABETES TECHNOLOGY &#038; THERAPEUTICS"}]},{"@type":"WebSite","@id":"https:\/\/ibima.eu\/es\/#website","url":"https:\/\/ibima.eu\/es\/","name":"Ibima","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibima.eu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635","name":"prodriguez","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","caption":"prodriguez"},"sameAs":["https:\/\/ibima.eu"],"url":"https:\/\/ibima.eu\/es\/author\/prodriguez\/"}]}},"_links":{"self":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/posts\/52317","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/comments?post=52317"}],"version-history":[{"count":1,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/posts\/52317\/revisions"}],"predecessor-version":[{"id":53157,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/posts\/52317\/revisions\/53157"}],"wp:attachment":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/media?parent=52317"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/categories?post=52317"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/tags?post=52317"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}